ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Krystal Biotech, Patient Impact Award"
Episode Synopsis
A new episode of Being a Life Sciences Leader, honoring the 2023 Patient Impact Award recipient, is now available. In this episode, Krish Krishnan, Chairman & CEO, and Suma Krishnan, President of Research & Development, discuss Krystal Biotech's VYJUVEK - the first ever FDA approved redosable gene therapy.
More episodes of the podcast Being a Life Sciences Leader
Bill Sibold, Madrigal Pharmaceuticals
29/04/2025
Devlin Robinson, PA State Senate
25/03/2025
Ben Doranz, PhD, MBA, Integral Molecular
11/03/2025
Adrian Rawcliffe, Adaptimmune
05/03/2025
Fred Vogt, Iovance Biotherapeutics
26/02/2025
Rob Albert, B. Braun
20/02/2025
Adele Oliva, 1315 Capital
29/01/2025
Jeff O'Donnell, Runway Healthcare
22/01/2025
In God we trust